期刊文献+

人乳头瘤病毒基因分型质控品的建立 被引量:9

The preparation of quality control materials for human papillomavirus genotyping
原文传递
导出
摘要 目的 建立HPV基因分型质控品.方法 收集宫颈脱落细胞标本300份,通过表面等离子谐振法和测序法检测标本型别,根据GenBank中参考序列设计各型别L1基因扩增引物,通过PCR扩增、连接转化构建包含不同型别L1基因重组质粒,通过30个重组质粒PCR鉴定和序列测定,并将测定序列用BLAST软件进行比对.结果 收集的标本包含了HPV 6、16、18等30种不同型别HPV感染.PCR扩增片段大小和设计引物扩增片段长度相符,除了HPV CP8304外,其余型别均在1 500~2 000 bp之间.重组质粒PCR鉴定与目的 片段相符,测序结果 与GenBank中的参考序列一致性在99%以上,在碱基数为1 500 bp的比对序列中不一致碱基数为11个.结论 建立了30种不同型别HPV L1基因分型质控品,覆盖了所有最常见型别,涵盖了14种高危型、3种中危型和13种低危型. Objective To prepare the HPV genotyping control materials. Methods Three hundred cervical smears with different HPV genotypes were collected and detected by surface plasmon resonance and sequencing. The primers for specific genotype were designed according to GenBank. The recombinant plasmid was constructed through PCR amplification, ligation and transformation. Thirty recombinant plasmids were identified through PCR amplification, sequencing, and the sequences were compared using BLAST. Results The collected HPV infectious samples contained 30 different genotypes including HPV 6,16,18 and so on.The fragment sequences of PCR amplification were concordant with the designed. The fragment sizes of the other types ranged from 1 500 to 2 000 bp except HPV CP8304. And the 30 recombinant plasmids identified by PCR were concordant with the target. The identity of BLAST was 99%. In the fragment of 1500 bp in length, 11 bases were inconsistent with the reference sequence. Conclusions Genotyping control materials were developed successfully. The human papillomavirns genotyping control materials covered all the most common types and included 14 types with high-risk, 3 types with medium-risk and 13 types with low-risk.
机构地区 北京 长春理工大学
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2010年第6期559-562,共4页 Chinese Journal of Laboratory Medicine
基金 体外诊断试剂国家标准品、参考品标定及复核项目(2011604) 重大传染病诊断产品质量评价综合技术平台(2009ZX10004-805)
关键词 乳头状瘤病毒科 基因型 试剂盒 诊断 Papillomaviridae Genotype Reagent kits,diagnostic
  • 相关文献

参考文献10

  • 1de Villiers EM,Fanquet C,Broker TR,et al.Classification of Papillomaviruses.Virology,2004,324:17-27.
  • 2Dell G,Gaston K.Human papillomaviruses and their role in cervical cancer.Cell Mol Life Sci,2001,58:1923-1942.
  • 3lifford GM,Smith JS,Aguado T,et al.Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer:a meta analysis.Br J Cancer,2003,89:101-105.
  • 4Liaw K L,Hildesheim A,Burk RD,et al.A prospective study of human Papillomavirus (HPV) type 16 DNA detection by Polymeras chain reaction and its association with acquisition and persistence of other HPV types.J Infect Dis,2001,183:8-15.
  • 5Gravitt PE,Peyton CL,Apple RJ,et al.Genotyping of 27 human papillomavirns types by using L1 consensus PCR products by a single-hybridization,reverse line blot detection method.J Clin Microbiol,1998,36:3020-3027.
  • 6Tieben LM,ter Schegget J,Minnsar RP,et al.Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers.J Virol Methods,1993,42:265-279.
  • 7van den Brule A J,Pol R,Fransen-Daalmeijer N,et al.GP5 +/6 + PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.J Clin Mierohiol,2002,40:779-787.
  • 8Khter B,van Doom LJ,Sehrauwen L,et al.Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.J Clin Mierobiol,1999,37:2508-2517.
  • 9Castle PE,Schiffman M,Burk RD,et al.Restricted crossreactivity of Hybrid capture 2 with nononcogenic human papillomavirus types.Cancer Epidemiol Biomarkers Prev,2002,11:1394-1399.
  • 10Munoz N,Bosch FX,de SanjoséS,et al.Epidemiologic classification of human papillomavirns types associated with cervical cancer.N Engl J Med,2003,348:518-527.

同被引文献95

  • 1郑莹,彭芝兰,楼江燕,王和.多重实时PCR对宫颈癌及癌前病变HPV-16病毒整合状态的检测[J].现代妇产科进展,2006,15(8):573-577. 被引量:14
  • 2高尚先,孙彬裕,曲守方,刘艳,孙楠,邹健.关于我国体外诊断试剂监督管理改革的建议[J].药物分析杂志,2006,26(8):1175-1180. 被引量:8
  • 3谢珊,李金明.人乳头瘤病毒16,18型核酸检测质控物的研制及应用[J].中华医学杂志,2007,87(26):1862-1866. 被引量:3
  • 4Nubia Munoz, F Xavier Bosch, Silvia de Sanjose, et al. Epidemiologic classification of human papillomavirus types associated with cervicad cancer. N Engl J Med,2003,348 (6) :518.
  • 5Jiang HL, Zhu HH, Zhou LF,et al. Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system , J Med Microbiol ,2006 ,5 5 (6) :715.
  • 6Adriaan JC, vanden Brule, Rene Pol, et al. GP5 +/6 + PCR followed by reverse line blot analysis enables rapid and high - throughput identification of human papillomavirus genotypes. J Clin Microbiol, 2002, 40(3 ) :779.
  • 7Wang R,Minunni M,Tombelli S,et al. A new approach for the detection of DNA sequences in amplified nucleic acids by a surface plasmon resonance biosensor. Biosens Bioelectron,2004,20(3) :598.
  • 8Halfon P, Trepo E, Antoniotti G, et al. Prospective evaluation of the hybrid capture 2 and amplicor human papillomavirus (HPV) tests for detection of 13 high - risk HPV genotypes in atypical squamous cells of uncertain significance. J Clin Microbio1,2007,45 (2) :313.
  • 9Giovannelli L, Lama A, Capra G, et al. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY - PCR compared to the hybrid capture Ⅱ and MY - PCR assays and a two - step nested PCR assay. J Clin Microbiol,2004,42 (8) :3861.
  • 10Calleja - Macias IE, Villa LL, Prado JC, et al. Worldwide genomic diversity of the high -risk human papillomavirus types 31,35,52, and 58 ,four close relatives of human papillomavirus type 16. J Virol, 2005,79 (21 ) : 13630.

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部